The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
暂无分享,去创建一个
[1] P. Wenaweser,et al. Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation. , 2013, European heart journal.
[2] J. Hausleiter,et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.
[3] O. Alfieri,et al. [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. , 2013, Giornale italiano di cardiologia.
[4] G. Feuchtner,et al. Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement , 2013, Circulation.
[5] Alexander Ghanem,et al. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. , 2013, Journal of the American College of Cardiology.
[6] C. Berry,et al. The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. , 2013, European heart journal.
[7] E. Foster,et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.
[8] T. Nazif,et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. , 2014, European heart journal.
[9] P. Jüni,et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. , 2013, European heart journal.
[10] M. Jahangiri,et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. , 2013, Journal of the American College of Cardiology.
[11] S. de Servi,et al. Interplay Between Mitral Regurgitation and Transcatheter Aortic Valve Replacement With the CoreValve Revalving System: A Multicenter Registry , 2013, Circulation.
[12] Sean M. O'Brien,et al. Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.
[13] M. Leon,et al. Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A , 2013, Circulation.
[14] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[15] Adriaan Moelker,et al. Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement , 2013, Circulation.
[16] S. de Servi,et al. Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System , 2013, Circulation.
[17] Anson Cheung,et al. 5-year outcome after transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.
[18] J. Bavaria,et al. Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis , 2013, Circulation.
[19] E. Tuzcu,et al. Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review. , 2013, Journal of the American College of Cardiology.
[20] C. Hengstenberg,et al. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results From the Global Valve-in-Valve Registry , 2012, Circulation.
[21] P. Jüni,et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). , 2013, European heart journal.
[22] R. Lange,et al. The German Aortic Valve Registry (GARY): in-hospital outcome , 2013, European heart journal.
[23] B. Iung,et al. Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. , 2013, European heart journal.
[24] G. Nickenig,et al. Transcatheter mitral valve replacement using a balloon-expandable prosthesis in a patient with calcified native mitral valve stenosis. , 2013, European heart journal.
[25] S. Connolly,et al. Dabigatran versus warfarin in patients with mechanical heart valves. , 2013, The New England journal of medicine.
[26] Timothy J Gardner,et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.
[27] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .
[28] J. Hung,et al. Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. , 2013, European heart journal.
[29] Antonio Colombo,et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. , 2014, Journal of the American College of Cardiology.